About SUTUREGARD® | A Linear Complex Wound Closure Device Company

Our Company

Dan Ladizinsky, MD
CEO and Co-Founder


Dan practiced plastic and reconstructive surgery for 29 years, consulted to the medical technology and biotechnology industries for over 25 years, and founded Oxygenesys, LLC and Galaxea, LLC.  He has helped bring wound healing medical device products to market and had a successful exit when Oxygenesys was acquired. He is a former fellow of the American College of Surgeons and has been board certified in General Surgery, Plastic Surgery and Surgery of the Hand. He is an expert in skin biology and wound healing (multiple publications and grants), and an inventor/author on multiple US patents. As staff surgeon at Kaiser Permanente Northwest, he held the roles of Chief of Plastic Surgery, ASC Chief of Staff and Chief Surgical Officer and was awarded as a Distinguished Physician by his colleagues. 

Jen Akeroyd, PhD
COO and Co-Founder


Before co-inventing the SUTUREGARD® device, Jen published in the fields of skin cancer and wound healing. She has won funding for SUTUREGARD® Medical through grants and pitch competitions (Pitch Oregon seed stage winner). Jen was named Entrepreneur of the Year in 2017 by RAIN Oregon.

Bill Lear, MD
CTO and Co-Founder


Bill is a board-certified dermatologist and fellowship-trained Mohs surgeon, he has published extensively on the topic of surgical devices and reconstruction in several textbook chapters and in peer-reviewed journals. He is a fellow of the American Academy of Dermatology and of the American College of Mohs Surgeons and is the Program Director of the Samaritan Health Services Micrographic Surgery and Dermatologic Oncology Fellowship Program. 

Ryan Egeland, MD, PhD
Member of the Board


Dr. Egeland joined CSI as Vice President of Medical Affairs in November of 2017. He has responsibilities providing global leadership, medical counsel and guidance to the organization on matters related to cardiovascular medicine, product and technology development, medical education, market development, quality assurance, clinical program design, clinical data analysis, regulatory affairs and business development. Prior to joining CSI, Dr. Egeland held roles in marketing, medical affairs and business development at Medtronic. Before this, he trained as a plastic and reconstructive surgeon at Northwestern Memorial Hospital, and received an MD with honors from Harvard Medical School. Dr. Egeland also holds a PhD in biochemistry and engineering from the University of Oxford, where he also completed a MBA as a Rhodes Scholar.

Mark Myerson, MD
Medical Advisor


Mark Myerson is a Professor of Orthopedic Surgery at the University of Colorado. He is the Medical Director of Steps2Walk, a humanitarian organization which coordinates the treatment of individuals with crippling foot and ankle deformities in underserved regions of the world while simultaneously educating the regional orthopedic surgeons in the management of these complex problems. Dr. Myerson is the foremost internationally recognized leader in reconstructive foot and ankle surgery and is Past President of the American Orthopaedic Foot and Ankle Society (AOFAS). He has been named a pioneer in orthopedic surgery by the American Academy of Orthopedic Surgeons (AAOS). He is a consultant to the orthopedic industry, an honorary member of many international orthopedic societies and plays an active role in defining national standards for orthopedic foot and ankle practice. Dr. Myerson has authored more than 350 research publications as well as six textbooks covering various treatments of foot and ankle conditions. He is a frequently invited guest speaker, giving professional talks around the world as consultant and educator. He has trained hundreds of orthopedic surgeons both in the United States and abroad, and education continues to be vital to his vision and mission. Dr. Myerson has developed numerous procedures for treating various foot and ankle injuries and deformities and his contributions to the field of orthopedic surgery have revolutionized the diagnosis, treatment, and recovery of foot and ankle disorders. Although Dr. Myerson has continued with clinical medicine, academic work, research, consulting, teaching, humanitarian activities and growing a global presence through Steps2Walk is his current primary focus.

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now